Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620120265> ?p ?o ?g. }
- W2620120265 endingPage "401" @default.
- W2620120265 startingPage "388" @default.
- W2620120265 abstract "© 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. The potential for harms from adverse drug reactions (ADR) constitutes a critical patient safety and public health challenge, especially with increased medication usage as populations age. The research reported here explores explanations for a sudden increase in ADR reporting in New Zealand after a new formulation of a medication to treat hypothyroidism, Eltroxin® (levothyroxine), was phased in. The formulation was adjudged to be bioequivalent to the old formulation, yet following its introduction, a sharp increase in the reporting of adverse reactions to this drug occurred. The paper analyses public engagement and the role of print media coverage, press releases and minutes of meetings of relevant agencies in order to describe the unfolding of this health controversy. Early interpretations of the sharp increase in reporting of reactions explained it as an outcome of a combination of factors, including a mistrust of state drug subsidising agencies and media attention that provoked anxiety in this vulnerable population. This paper offers an alternative explanation arguing that, as adverse drug reactions are known to be significantly underreported, the Eltroxin® ‘health scare’ illustrates enhanced pharmacovigilance triggered by the interaction between patients and the media. The Eltroxin® controversy is an illustrative case example of the amplification of ADR reporting by patients following increased media attention in the context of a low consumer reporting environment. The case of Eltroxin® indicates that drug safety can be enhanced by actively using media sources and by encouraging patient engagement and reporting of ADRs." @default.
- W2620120265 created "2017-06-05" @default.
- W2620120265 creator A5010992089 @default.
- W2620120265 creator A5016240895 @default.
- W2620120265 creator A5027742316 @default.
- W2620120265 creator A5030495520 @default.
- W2620120265 creator A5030939146 @default.
- W2620120265 creator A5041482894 @default.
- W2620120265 creator A5080803364 @default.
- W2620120265 date "2017-05-22" @default.
- W2620120265 modified "2023-09-27" @default.
- W2620120265 title "Public engagement and the role of the media in post-marketing drug safety: the case of Eltroxin® (levothyroxine) in New Zealand" @default.
- W2620120265 cites W100677827 @default.
- W2620120265 cites W122320840 @default.
- W2620120265 cites W158794602 @default.
- W2620120265 cites W1969879564 @default.
- W2620120265 cites W1974924465 @default.
- W2620120265 cites W1976079356 @default.
- W2620120265 cites W1979812611 @default.
- W2620120265 cites W1989389124 @default.
- W2620120265 cites W1998662106 @default.
- W2620120265 cites W2001260651 @default.
- W2620120265 cites W2009890917 @default.
- W2620120265 cites W2018572610 @default.
- W2620120265 cites W202909624 @default.
- W2620120265 cites W2031360325 @default.
- W2620120265 cites W2033295329 @default.
- W2620120265 cites W2037826182 @default.
- W2620120265 cites W2054340477 @default.
- W2620120265 cites W2066224726 @default.
- W2620120265 cites W2078261174 @default.
- W2620120265 cites W2081030282 @default.
- W2620120265 cites W2093320097 @default.
- W2620120265 cites W2108903661 @default.
- W2620120265 cites W2114785584 @default.
- W2620120265 cites W2145549479 @default.
- W2620120265 cites W2169559966 @default.
- W2620120265 cites W2336538145 @default.
- W2620120265 cites W2516356692 @default.
- W2620120265 cites W4323253719 @default.
- W2620120265 cites W982319484 @default.
- W2620120265 doi "https://doi.org/10.1080/09581596.2017.1329520" @default.
- W2620120265 hasPublicationYear "2017" @default.
- W2620120265 type Work @default.
- W2620120265 sameAs 2620120265 @default.
- W2620120265 citedByCount "6" @default.
- W2620120265 countsByYear W26201202652018 @default.
- W2620120265 countsByYear W26201202652019 @default.
- W2620120265 countsByYear W26201202652021 @default.
- W2620120265 countsByYear W26201202652022 @default.
- W2620120265 crossrefType "journal-article" @default.
- W2620120265 hasAuthorship W2620120265A5010992089 @default.
- W2620120265 hasAuthorship W2620120265A5016240895 @default.
- W2620120265 hasAuthorship W2620120265A5027742316 @default.
- W2620120265 hasAuthorship W2620120265A5030495520 @default.
- W2620120265 hasAuthorship W2620120265A5030939146 @default.
- W2620120265 hasAuthorship W2620120265A5041482894 @default.
- W2620120265 hasAuthorship W2620120265A5080803364 @default.
- W2620120265 hasBestOaLocation W26201202652 @default.
- W2620120265 hasConcept C126322002 @default.
- W2620120265 hasConcept C138816342 @default.
- W2620120265 hasConcept C151730666 @default.
- W2620120265 hasConcept C159110408 @default.
- W2620120265 hasConcept C17744445 @default.
- W2620120265 hasConcept C2775883008 @default.
- W2620120265 hasConcept C2779343474 @default.
- W2620120265 hasConcept C2780035454 @default.
- W2620120265 hasConcept C2908647359 @default.
- W2620120265 hasConcept C2993432071 @default.
- W2620120265 hasConcept C39549134 @default.
- W2620120265 hasConcept C57658597 @default.
- W2620120265 hasConcept C71315377 @default.
- W2620120265 hasConcept C71924100 @default.
- W2620120265 hasConcept C86803240 @default.
- W2620120265 hasConcept C98274493 @default.
- W2620120265 hasConcept C99454951 @default.
- W2620120265 hasConceptScore W2620120265C126322002 @default.
- W2620120265 hasConceptScore W2620120265C138816342 @default.
- W2620120265 hasConceptScore W2620120265C151730666 @default.
- W2620120265 hasConceptScore W2620120265C159110408 @default.
- W2620120265 hasConceptScore W2620120265C17744445 @default.
- W2620120265 hasConceptScore W2620120265C2775883008 @default.
- W2620120265 hasConceptScore W2620120265C2779343474 @default.
- W2620120265 hasConceptScore W2620120265C2780035454 @default.
- W2620120265 hasConceptScore W2620120265C2908647359 @default.
- W2620120265 hasConceptScore W2620120265C2993432071 @default.
- W2620120265 hasConceptScore W2620120265C39549134 @default.
- W2620120265 hasConceptScore W2620120265C57658597 @default.
- W2620120265 hasConceptScore W2620120265C71315377 @default.
- W2620120265 hasConceptScore W2620120265C71924100 @default.
- W2620120265 hasConceptScore W2620120265C86803240 @default.
- W2620120265 hasConceptScore W2620120265C98274493 @default.
- W2620120265 hasConceptScore W2620120265C99454951 @default.
- W2620120265 hasFunder F4320332177 @default.
- W2620120265 hasFunder F4320334749 @default.
- W2620120265 hasIssue "4" @default.
- W2620120265 hasLocation W26201202651 @default.
- W2620120265 hasLocation W26201202652 @default.